MiR-564 is down-regulated in osteosarcoma and inhibits the proliferation of osteosarcoma cells via targeting Akt

Area of Science:

• Molecular Biology
• Oncology
• Biochemistry

Background:

• Aberrant microRNA (miRNA) expression is a hallmark of human cancers.
• Specific miRNAs play crucial roles in tumor development and progression.
• The role of miR-564 in osteosarcoma (OS) pathogenesis remains largely unexplored.

Purpose of the Study:

• To investigate the expression and function of miR-564 in human osteosarcoma.
• To elucidate the molecular mechanism underlying miR-564's role in OS.
• To assess the therapeutic potential of targeting the miR-564-Akt axis in OS.

Main Methods:

• Quantitative real-time PCR to assess miR-564 expression in OS cell lines and patient samples.
• Cell proliferation and apoptosis assays in OS cells with miR-564 overexpression.
• Western blotting and luciferase reporter assays to validate Akt as a direct target of miR-564.
• Rescue experiments to confirm the functional significance of the miR-564-Akt interaction.

Main Results:

• miR-564 expression was significantly downregulated in human osteosarcoma cell lines and patient tissues.
• Overexpression of miR-564 suppressed OS cell proliferation and induced apoptosis.
• miR-564 directly targets Akt, reducing its mRNA and protein levels, thereby inhibiting glycolysis and cell growth in OS cells.
• Restoration of Akt expression reversed the inhibitory effects of miR-564 on glucose metabolism and cell proliferation.

Conclusions:

• miR-564 functions as a tumor suppressor in osteosarcoma.
• The miR-564-Akt signaling pathway regulates glycolysis and cell proliferation in OS.
• Targeting the miR-564-Akt axis presents a promising therapeutic strategy for osteosarcoma treatment.